共 8 条
[3]
Lewin A, 2018, EPIDEMIOLOGY, V29, P87, DOI [10.1097/EDE.0000000000000755, 10.1097/ede.0000000000000755]
[4]
Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment
[J].
PLOS ONE,
2019, 14 (10)
[6]
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
[J].
LANCET GASTROENTEROLOGY & HEPATOLOGY,
2021, 6 (02)
:106-119